BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Globe Newswire • 28 days ago
RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors...
Share to Feed
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Get Free Report) has received an average recommendation of "Buy" from the seven ratings firms that are presently covering the stock, Marketbeat reports...
RESEARCH TRIANGLE PARK, N.C., March 25, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the H.C. Wainwright 2nd Annual...
Adverum Biotechnologies (NASDAQ:ADVM Get Free Report) and BioCryst Pharmaceuticals (NASDAQ:BCRX Get Free Report) are both small-cap medical companies, but which is the superior...
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX Get Free Report) have received an average recommendation of Buy from the seven research firms that are presently covering...
RESEARCH TRIANGLE PARK, N.C., March 05, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors...
This is a signal that BCRX's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
ELCO Management Co. LLC grew its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX Free Report) by 134.9% during the third quarter, Holdings Channel reports. The institutional...
Related Stocks: FRA:BO1...
Related Stocks: NAS:BCRX...